Eagle Boston Investment Management Inc. trimmed its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 13.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 344,344 shares of the medical instruments supplier’s stock after selling 51,877 shares during the period. Merit Medical Systems accounts for about 1.9% of Eagle Boston Investment Management Inc.’s investment portfolio, making the stock its 4th biggest holding. Eagle Boston Investment Management Inc.’s holdings in Merit Medical Systems were worth $21,159,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of the company. Alliancebernstein L.P. boosted its holdings in shares of Merit Medical Systems by 3.5% during the 3rd quarter. Alliancebernstein L.P. now owns 120,114 shares of the medical instruments supplier’s stock valued at $7,381,000 after acquiring an additional 4,100 shares during the last quarter. Eagle Asset Management Inc. boosted its holdings in shares of Merit Medical Systems by 1.0% during the 3rd quarter. Eagle Asset Management Inc. now owns 2,045,983 shares of the medical instruments supplier’s stock valued at $125,725,000 after acquiring an additional 19,863 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of Merit Medical Systems by 22.5% during the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,067 shares of the medical instruments supplier’s stock valued at $803,000 after acquiring an additional 2,403 shares during the last quarter. Piedmont Investment Advisors Inc. boosted its holdings in shares of Merit Medical Systems by 7.4% during the 3rd quarter. Piedmont Investment Advisors Inc. now owns 12,588 shares of the medical instruments supplier’s stock valued at $774,000 after acquiring an additional 863 shares during the last quarter. Finally, Rhumbline Advisers boosted its holdings in shares of Merit Medical Systems by 4.8% during the 3rd quarter. Rhumbline Advisers now owns 124,474 shares of the medical instruments supplier’s stock valued at $7,649,000 after acquiring an additional 5,669 shares during the last quarter. 87.15% of the stock is owned by hedge funds and other institutional investors.

MMSI opened at $61.28 on Friday. The company has a current ratio of 2.77, a quick ratio of 1.47 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $3.17 billion, a P/E ratio of 47.88, a price-to-earnings-growth ratio of 2.67 and a beta of 1.19. Merit Medical Systems, Inc. has a 12-month low of $40.20 and a 12-month high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Thursday, October 25th. The medical instruments supplier reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.05. The company had revenue of $221.66 million for the quarter, compared to the consensus estimate of $217.62 million. Merit Medical Systems had a net margin of 4.72% and a return on equity of 10.86%. On average, equities research analysts predict that Merit Medical Systems, Inc. will post 1.66 earnings per share for the current year.

In related news, Director F. Ann Millner sold 9,593 shares of the firm’s stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $56.92, for a total value of $546,033.56. Following the transaction, the director now owns 7,891 shares of the company’s stock, valued at $449,155.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Ronald Frost sold 5,257 shares of Merit Medical Systems stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $61.31, for a total transaction of $322,306.67. Following the transaction, the chief operating officer now directly owns 5,257 shares in the company, valued at approximately $322,306.67. The disclosure for this sale can be found here. Company insiders own 5.00% of the company’s stock.

A number of analysts have recently issued reports on the stock. Sidoti set a $79.00 price target on shares of Merit Medical Systems and gave the company a “buy” rating in a report on Tuesday, October 2nd. Piper Jaffray Companies raised their price target on shares of Merit Medical Systems from $58.00 to $72.00 and gave the company an “overweight” rating in a report on Tuesday, October 2nd. Barrington Research raised their price target on shares of Merit Medical Systems to $69.00 and gave the company an “outperform” rating in a report on Tuesday, October 2nd. Needham & Company LLC raised their price target on shares of Merit Medical Systems from $67.00 to $73.00 and gave the company a “buy” rating in a report on Tuesday, October 2nd. Finally, Zacks Investment Research downgraded shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a report on Wednesday, October 24th. One analyst has rated the stock with a sell rating, nine have given a buy rating and two have given a strong buy rating to the stock. Merit Medical Systems has a consensus rating of “Buy” and a consensus target price of $68.10.

COPYRIGHT VIOLATION NOTICE: “Merit Medical Systems, Inc. (MMSI) is Eagle Boston Investment Management Inc.’s 4th Largest Position” was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.dailypolitical.com/2018/11/18/merit-medical-systems-inc-mmsi-is-eagle-boston-investment-management-inc-s-4th-largest-position.html.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.

Recommended Story: How to read a candlestick chart

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.